Watch KIDS. Know when insiders buy.
One email the day a filing lands. Free.
Work order
36
FLAG · insiders 25, shorts 46
Insiders, 90 days
−$27.7M
net selling · 0 buys, 18 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $589.8MP/E —DIV YIELD —FCF YIELD -0.31%REV TTM $252.7M +14.5%NET INCOME −$39.7MNET DEBT $88.8M52W 14.64 – 26.50NEXT EARNINGS Oct 28 EST.SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $70.5M | +15.4% | 74.3% | −$4.1M | −$7.2M | — | -0.30 | $928K | $4M | −$3.1M | Aug 5 |
| Q1 2026 · Mar 31 | $59.4M | +13.3% | 73.1% | −$8.3M | −$10.7M | — | -0.45 | −$3.3M | $1.8M | −$5M | Aug 5 |
| Q4 2025 · Dec 31derived | $61.6M | +17.0% | 73.2% | −$8.2M | −$10.1M | — | -0.43 | $10.3M | $599K | $9.7M | Mar 4 |
| Q3 2025 · Sep 30 | $61.3M | +12.2% | 73.9% | −$9.4M | −$11.8M | — | -0.50 | −$581K | $2.8M | −$3.4M | Oct 29 |
| Q2 2025 · Jun 30 | $61.1M | +15.7% | 72.1% | −$10.7M | −$7.1M | — | -0.30 | −$10.5M | $3.4M | −$13.9M | Aug 5 |
| Q1 2025 · Mar 31 | $52.4M | +17.3% | 73.0% | −$11M | −$10.7M | — | -0.46 | −$4.2M | $4.2M | −$8.4M | Aug 5 |
| Q4 2024 · Dec 31derived | $52.7M | +40.0% | 67.5% | −$14.1M | −$16.1M | — | -0.70 | −$4M | −$262K | −$3.7M | Mar 4 |
| Q3 2024 · Sep 30 | $54.6M | +36.5% | 73.4% | −$5.6M | −$7.9M | — | -0.34 | −$10.3M | $1.4M | −$11.7M | Oct 29 |
| Q2 2024 · Jun 30 | $52.8M | — | 77.3% | −$5.7M | −$6M | — | -0.26 | −$6.1M | $6.7M | −$12.8M | Oct 29 |
| Q1 2024 · Mar 31 | $44.7M | — | 72.0% | −$9.7M | −$7.8M | — | -0.34 | −$6.7M | $6.5M | −$13.2M | Oct 29 |
| Q4 2023 · Dec 31derived | $37.6M | — | 71.0% | −$8.1M | −$6.7M | — | -0.29 | −$7.5M | $3.8M | −$11.4M | Mar 4 |
| Q3 2023 · Sep 30 | $40M | — | 77.4% | −$4.5M | −$4.6M | — | -0.20 | −$8.7M | $2.5M | −$11.1M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $236.3M | 73.1% | −$39.2M | −$39.6M | -16.8% | -1.69 | −$4.9M | $11.1M | −$16M | — | — |
| FY2024 · to Dec 31 | $204.7M | 72.6% | −$35M | −$37.8M | -18.5% | -1.64 | −$27M | $14.3M | −$41.3M | — | — |
| FY2023 · to Dec 31 | $148.7M | 74.8% | −$26.8M | −$21M | -14.1% | -0.92 | −$27M | $16.9M | −$43.9M | — | — |
| FY2022 · to Dec 31 | $122.3M | 74.1% | −$25.4M | $1.3M | 1.0% | 0.06 | −$21.8M | $10M | −$31.8M | — | — |
| FY2021 · to Dec 31 | $98M | 74.9% | −$18M | −$16.3M | -16.6% | -0.84 | −$13.1M | $8.1M | −$21.2M | — | — |
| FY2020 · to Dec 31 | $71.1M | 77.4% | −$26.8M | −$32.9M | -46.3% | -1.82 | −$18.5M | $10.5M | −$29M | — | — |
Every number comes from ORTHOPEDIATRICS CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.